Jiansen Lu

994 total citations · 1 hit paper
19 papers, 742 citations indexed

About

Jiansen Lu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Jiansen Lu has authored 19 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Jiansen Lu's work include interferon and immune responses (7 papers), Autophagy in Disease and Therapy (6 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Jiansen Lu is often cited by papers focused on interferon and immune responses (7 papers), Autophagy in Disease and Therapy (6 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Jiansen Lu collaborates with scholars based in China, United States and Australia. Jiansen Lu's co-authors include Xiaochun Bai, Daozhang Cai, Jianying Pan, Denghui Xie, Yan Shao, Chun Zeng, Chang Zhao, Haiyan Zhang, Hua Wang and Yue Zhang and has published in prestigious journals such as Nature Communications, PLoS Biology and Science Advances.

In The Last Decade

Jiansen Lu

18 papers receiving 740 citations

Hit Papers

Synovial macrophage M1 polarisation exacerbates experimen... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiansen Lu China 9 369 335 158 122 115 19 742
Jianying Pan China 14 530 1.4× 431 1.3× 148 0.9× 106 0.9× 179 1.6× 29 988
Takahiro Iino Japan 20 179 0.5× 289 0.9× 123 0.8× 221 1.8× 51 0.4× 50 869
A.-M. Zuurmond Netherlands 10 774 2.1× 269 0.8× 171 1.1× 126 1.0× 211 1.8× 12 1.1k
Debabrata Patra United States 15 277 0.8× 462 1.4× 55 0.3× 220 1.8× 74 0.6× 28 873
Anak A. S. S. K. Dharmapatni Australia 15 156 0.4× 294 0.9× 152 1.0× 109 0.9× 56 0.5× 18 557
Jean-Noël Gouze United States 18 577 1.6× 467 1.4× 102 0.6× 121 1.0× 209 1.8× 28 1.2k
Jeng‐Long Hsieh Taiwan 15 222 0.6× 153 0.5× 49 0.3× 69 0.6× 104 0.9× 22 544
Rui‐Sheng Xu China 17 125 0.3× 576 1.7× 162 1.0× 184 1.5× 36 0.3× 25 950
Tao Gui China 15 201 0.5× 189 0.6× 46 0.3× 73 0.6× 66 0.6× 30 584
K.B. Marcu United States 7 287 0.8× 264 0.8× 137 0.9× 86 0.7× 108 0.9× 12 634

Countries citing papers authored by Jiansen Lu

Since Specialization
Citations

This map shows the geographic impact of Jiansen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiansen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiansen Lu more than expected).

Fields of papers citing papers by Jiansen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiansen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiansen Lu. The network helps show where Jiansen Lu may publish in the future.

Co-authorship network of co-authors of Jiansen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiansen Lu. A scholar is included among the top collaborators of Jiansen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiansen Lu. Jiansen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lu, Jiansen, et al.. (2026). Dynamic regulation of TBK1 lactylation shapes antiviral immune responses. Cellular and Molecular Immunology. 23(3). 284–300.
2.
Jiang, Huaji, Z. Hu, Jiansen Lu, et al.. (2025). VANGL2 alleviates inflammatory bowel disease by recruiting the ubiquitin ligase MARCH8 to limit NLRP3 inflammasome activation through OPTN-mediated selective autophagy. PLoS Biology. 23(2). e3002961–e3002961. 3 indexed citations
3.
Lu, Jiansen, Zhiqiang Hu, Huaji Jiang, et al.. (2024). Dual nature of type I interferon responses and feedback regulations by SOCS1 dictate malaria mortality. Journal of Advanced Research. 73. 295–310. 1 indexed citations
4.
Lu, Jiansen, Huaji Jiang, Z. Hu, et al.. (2024). Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation. eLife. 12. 2 indexed citations
5.
Hu, Zhiqiang, B. Fan, Ke Zeng, et al.. (2024). The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐T. Gondii Immunity and Tumor Immunotherapy. Advanced Science. 11(32). e2400952–e2400952. 4 indexed citations
6.
Hu, Z., Jiansen Lu, Huaji Jiang, et al.. (2023). VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation. Science Advances. 9(25). eadg2339–eadg2339. 15 indexed citations
7.
Jiang, Huaji, Jiansen Lu, Hongyu Li, et al.. (2023). Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy. Autophagy. 20(1). 76–93. 26 indexed citations
8.
Yang, Shuang, Jiansen Lu, Yuan Shi, et al.. (2023). Hypothermic machine perfusion alleviates ischemia-reperfusion injury of intestinal transplantation in pigs. Frontiers in Immunology. 14. 1117292–1117292. 8 indexed citations
9.
Lu, Jiansen, Huaji Jiang, Zhiqiang Hu, et al.. (2023). Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation. eLife. 12. 3 indexed citations
10.
Lu, Jiansen, et al.. (2023). Trans-anethole pretreatment ameliorates hepatic ischemia–reperfusion injury via regulation of soluble epoxide hydrolase. International Immunopharmacology. 124(Pt A). 110809–110809. 4 indexed citations
11.
Yang, Shuai, Ke Zeng, Jiayin Guo, et al.. (2023). SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy. mBio. 14(4). e0351222–e0351222. 2 indexed citations
12.
Du, Yang, Zhiqiang Hu, Jiansen Lu, et al.. (2022). Activation of cGAS‐STING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b+Ly6Chi Proinflammatory Monocytes. Advanced Science. 9(22). e2103701–e2103701. 11 indexed citations
13.
Wang, Wenhao, Jiansen Lu, Ying Song, et al.. (2022). Repair of bone defects in rhesus monkeys with α1,3-galactosyltransferase-knockout pig cancellous bone. Frontiers in Bioengineering and Biotechnology. 10. 990769–990769. 1 indexed citations
14.
Hu, Zhiqiang, Dan Wu, Jiansen Lu, et al.. (2022). Inflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti- Toxoplasma Immunity. mBio. 13(6). e0236122–e0236122. 13 indexed citations
15.
Lu, Jiansen, Hongbo Zhang, Jianying Pan, et al.. (2021). Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways. Arthritis Research & Therapy. 23(1). 142–142. 79 indexed citations
16.
Lu, Jiansen, Hong Guan, Dan Wu, et al.. (2021). Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway. Journal of Cellular and Molecular Medicine. 25(14). 6664–6678. 19 indexed citations
17.
Zhang, Haiyan, Chuangxin Lin, Chun Zeng, et al.. (2018). Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Annals of the Rheumatic Diseases. 77(10). 1524–1534. 349 indexed citations breakdown →
18.
Lu, Jiansen, Haiyan Zhang, Daozhang Cai, et al.. (2018). Positive-Feedback Regulation of Subchondral H-Type Vessel Formation by Chondrocyte Promotes Osteoarthritis Development in Mice. Journal of Bone and Mineral Research. 33(5). 909–920. 79 indexed citations
19.
Huang, Bin, Wenhao Wang, Qingchu Li, et al.. (2016). Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone. Nature Communications. 7(1). 13885–13885. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026